As the COVID-19 outbreak continues to evolve, organizations are navigating the various stages of the M&A and transaction lifecycle to maximize their value. Whether acting as a buy- or sell-side participant, Kroll has a proven track record helping clients identify and investigate potential problems and assess the various financial and operational strategies available through every stage of a deal. Our team of experts is ready to assist and provide sound advice on distressed M&A, cash availability analysis, comprehensive due diligence, fairness opinions, disputes and restructuring considerations, among others.
Learn more about our COVID-19 risk management solutions.
Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.
Kroll professionals have advised hundreds of companies, investors and other stakeholders at all stages of distressed transactions and special situations.